$LLY INSIGHTS →Eli Lilly’s ($LLY) olomorasib received FDA Breakthrough Therapy designation for treating advanced KRAS G12C-mutated pancreatic cancer.
Read the full research in the app
A subscription is required to access the full thread.
Open in the app →